Over Expression of Metallothionein Predicts Resistance of Transitional Cell Carcinoma of Bladder to Intravesical Mitomycin Therapy
- 1 February 2003
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 169 (2) , 721-723
- https://doi.org/10.1016/s0022-5347(05)64001-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Prognostic evaluation of metallothionein expression in human colorectal neoplasms.Journal of Clinical Pathology, 1999
- High metallothionein expression is associated with features predictive of aggressive behaviour in endometrial carcinomaHistopathology, 1999
- Significance of metallothionein overexpression in human tumoursHistopathology, 1997
- Metallothionein expression in human breast cancerBritish Journal of Cancer, 1995
- Metallothionein III is expressed in neurons that sequester zinc in synaptic vesiclesJournal of Neuroscience, 1994
- Induction of a New Metallothionein Isoform (MT-IV) Occurs during Differentiation of Stratified Squamous EpitheliaBiochemistry, 1994
- Contemporary Issues in ToxicologyToxicology and Applied Pharmacology, 1994
- Recurrence of superficial bladder tumours after transurethral resectionInternational Urology and Nephrology, 1992
- Thionein (apometallothionein) can modulate DNA binding and transcription activation by zinc finger containing factor SplFEBS Letters, 1991
- Amino-acid sequence of equine renal metallothionein-1B.Proceedings of the National Academy of Sciences, 1976